Related Experiment Video
Updated: Apr 15, 2026

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
Published on: December 9, 2022
[Present and future in the management of venous vascular diseases]
Insights
Chronic venous vascular diseases are globally prevalent, with severe cases underestimated. Micronized purified flavonoid fraction (MPFF) is recommended for leg ulcers, alongside other treatments for venous conditions and thrombosis prevention.
Area of Science:
- Vascular Medicine
- Phlebology
- Epidemiology
Background:
- Chronic and acute venous vascular diseases exhibit high global prevalence.
- Advanced venous failure cases are more common than previously estimated.
- Venous diseases significantly impact public health worldwide.
Purpose of the Study:
- To review current understanding and management of chronic and acute venous vascular diseases.
- To highlight effective therapeutic options for venous insufficiency and thrombosis.
- To emphasize the significance of venous diseases as a global health concern.
Main Methods:
- Review of epidemiological data on venous vascular disease prevalence and incidence.
- Analysis of current pharmacotherapeutic options, including venoactive drugs (VADs) and anticoagulants.
- Evaluation of invasive treatment modalities like compressive sclerotherapy.
Main Results:
- Micronized purified flavonoid fraction (MPFF) is a highly recommended VAD for leg ulcer healing.
- Compressive sclerotherapy is effective for treating superficial venous abnormalities.
- Direct oral anticoagulants (DOACs) are key for deep venous thrombosis (DVT) and venous thromboembolism (VTE) prevention, with specific limitations.
Conclusions:
- Venous vascular diseases represent a significant global health challenge.
- A combination of pharmacotherapy and interventional procedures offers effective management strategies.
- Prophylaxis against venous thromboembolism is crucial, especially in high-risk populations.
Abstract:
The prevalence and the incidence of chronic and acute venous vascular disease has been shown to be globally very high, in both industrialized and developing countries. Chronic venous diseases of lower extremities are being an integral part of the third millennium's deadly angiopandemy, at the present time. The rate of the most severe cases with advanced stage of venous failure is approximately twice as high in the population (2.1 %) as has been assumed so far. Among venoactive drugs (VAD), micronized purified flavonoid fraction (MPFF) of diosmin hesperidin remains the agent with the highest degree of recommendation and it also indicated to pharmacotherapeutical support of leg ulcer healing, along with sulodexide and pentoxifylline. Compressive sclerotherapy, liquid or foam, is a safe and effective invasive method to treat telangiectasias, reticular varicose veins and subcutaneous varicose veins. Direct oral anticoagulants (DOAC) represent one of the therapeutic and preventive options of deep venous thrombosis (DVT) and of venous thromboembolism (VTE) with a limitation in patients with malignant conditions and in pregnancy. The most effective is triple simultaneous pharmaco-kinezio-mechano-phlebothromboemboloprophylaxis. Superficial vein thromboses longer than 5 cm are indicated to anticoagulant therapy too.
More Related Videos
07:02A Rabbit Venous Interposition Model Mimicking Revascularization Surgery using Vein Grafts to Assess Intimal Hyperplasia under Arterial Blood Pressure
Published on: May 15, 2020
05:44Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins
Published on: May 24, 2024
Related Concept Videos
Venous Thrombosis IV: Nursing Management
Venous Thrombosis III: Interprofessional Care
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Venous Return
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies